Kimberly-Clark reports progress to sustainability 2022 goals
Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value.
CDR
HeadBlade names Tom Wainman as new brand spokesperson
HeadBlade, a leader in HeadCare and developers of the ultimate head shaving razor, the HeadBlade MOTO, announced Tom Wainman, formerly a pitchman for Hair Club for Men, as its new spokesperson.
AcneFree and AARS team to help new generation of acne sufferers
AcneFree announces its support of the American Acne and Rosacea Society (AARS), a non-profit organization, as a part of its commitment to better educate the 21 million teenagers in the U.S. – approximately 80% of all teens – who suffer from acne and occasional breakouts.
Upsher-Smith featuring Platinum Pass at AHS meeting
Upsher-Smith Laboratories (Upsher-Smith) announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28 to July 1, in
MinuteClinic offering hepatitis A vaccine in Ohio following outbreak
MinuteClinic, the retail medical clinic of CVS Health, is encouraging unvaccinated Ohio residents to receive the hepatitis A vaccine following an increase in confirmed cases of the virus.
FDA grants priority review to single-dose flu drug
Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.
FDA approves first marijuana-based prescription drug
The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
Aurobindo receives FDA approval for ertapenem injection
Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.
Dove making a new mark in beauty imagery
Starting next month, Dove will be taking another step in ensuring beauty is a source of confidence and not anxiety with the launch of a ‘No Digital Distortion Mark’. The Mark will roll out across all branded content globally beginning in July with deodorant campaigns leading the initiative.
Dove Chocolate’s Cocoa Farmers Market goes from bean to bar
Dove Chocolate is hosting the first-ever Cocoa Farmers Market at Santa Monica Place in Los Angeles, an interactive experience detailing the chocolate-making journey from bean to bar.
Harmony Herbal offers Skin Therapy Calm and Calm + Detox
Earlier this year, Harmony Herbal introduced Skin Therapy Calm and Calm + Detox, said to be the first herbal medicine-based supplement and topical combination duo to relieve the symptoms of rash, eczema and dermatitis with a whole body wellness approach.
Rite Aid sends letter to shareholders detailing merits of merger
Rite Aid Corp. today announced that the registration statement on Form S-4, in connection with its proposed merger with Albertsons Cos., has been declared effective by the U.S. Securities and Exchange Commission (SEC).
Jif partners with Neil Patrick Harris for Power Ups launch
To celebrate the roll out of new Jif Power Ups peanut butter snacks, the brand is teaming with multi-talented award-winning actor and father of two, Neil Patrick Harris, to shed a humorous light on trending parenting challenges and introduce the ultimate win-win solution that is equal parts deliciou
Elise Donahue joins board at Vizuri Health Sciences
Vizuri Health Sciences announced that the company has further strengthened its consumer healthcare operational and transactional experience by adding Elise Donahue to its board of directors.
Lilly presents new diabetes data at ADA session
Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog.
AllianceRx Walgreens Prime, Inovalon team up
AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime) announced today a collaboration with Inovalon, a leading technology company providing cloud-based platforms empowering data-driven hea